[Event Report] AMR Special Symposium “Reframing AMR as the Infrastructure Guarding the World: Building Multi-Stakeholder Commitment to the One Health Approach Looking to the G7, UNGA, and Beyond” (February 28, 2023)
date : 3/10/2023
Tags: AMR
![[Event Report] AMR Special Symposium “Reframing AMR as the Infrastructure Guarding the World: Building Multi-Stakeholder Commitment to the One Health Approach Looking to the G7, UNGA, and Beyond” (February 28, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-20230228-top.jpg)
Health and Global Policy Institute (HGPI) hosted a AMR special symposium “Reframing AMR as the Infrastructure Guarding the World: Building Multi-Stakeholder Commitment to the One Health Approach Looking to the G7, UNGA, and Beyond” which is supported by British Embassy, Tokyo and Department of Health & Social Care, UK, European Bank for Reconstruction and Development (EBRD).
This symposium aimed to bring together stakeholders from various fields related to AMR to examine the ways in which society should collaborate, including discussions on what each sector can do to further AMR countermeasures towards the G7 Summit, the UN General Assembly (UNGA) and beyond. The voice of AMR patient was also shared with participants at the symposium.
The event report will be published in the website in due course.
[Overview]
- Date and Time: February 28, 2023, 15:00-17: 00 JST
- Venue: Kudan-Kaikan Terrace Conference & Banquet
- Languages: Japanese and English (simultaneous translation was available)
- Hosted by: Health and Global Policy Institute
- Supported by: British Embassy, Tokyo and Department of Health & Social Care, UK, European Bank for Reconstruction and Development (EBRD)
[Program] (Titles omitted)
15:00-15:05 Welcome and Introductory Remarks
Ryoji Noritake (CEO and Board Member, HGPI)
15:05-15:25 Keynote Speech “Actions Required for AMR Countermeasures”
Dame Sally Davies (UK Government Special Envoy on Antimicrobial Resistance)
15:25-15:40 Presentation “Challenges in the Antimicrobial Market – Incentives for R&D and Access”
Takuko Sawada (Director and Vice Chairperson of the Board, Shionogi & Co., Ltd.)
15:40-15:55 Presentation “The Position of AMR Within ESG Finance”
Kenji Fuma (CEO, Neural, Inc. / Specially Appointed Professor, Shinshu University)
15:55-16:10 Presentation “Role of Multi-stakeholder Coalition in the Pandemic Era”
Naoko Ishii (Executive Vice President, the University of Tokyo / Director, Center for Global Commons/ Professor, Institute for Future Initiatives / Member, Global Preparedness Monitoring Board (GPMB))
16:10-16:15 Patient Voice “My experience of Antimicrobial Resistance”
Junichi Maruyama (Previous Ambassador of Japan to Serbia)
16:15-16:55 Multi-stakeholder Discussion “Your Commitment, Our Commitment”
16:55-17:00 Closing Remarks
Ryoji Noritake (CEO and Board Member, HGPI)
(Photographed by: Kazunori Izawa)
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Declares the Ministry of the Environment-led ‘Deco-Katsu Declaration’ and Participation in the ‘Deco-Katsu’ Supporters (October 16, 2023)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (AMR Alliance Japan, December 22, 2021)
Featured Posts
-
2023-10-31
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
-
2023-11-27
[Registration Open] (Webinar) HGPI Cooperation with Lancet Countdown 2023 Japan Presentation “Climate Change as a Children’s Health Issue: The Latest Lancet Report Sounds the Alarm for Health Commitments” (December 14, 2023)
-
2023-11-28
[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) Support Project “Necessary Steps for Promoting PPI in Policy Making” (October 3, 2023)
-
2023-11-29
[Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
-
2023-11-30
[Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)